Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: A prospective study of more than 70 consecutive patients

European Journal of Endocrinology

Volumn 155, Issue 5, 2006, Pages 709-715

  Ueland, Thor ^a,b   Fougner, S L ^a,b   Godang, K ^a   Schreiner, T ^a   Bollerslev, J ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; BIOCHEMISTRY; BIOMECHANICS; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GONAD; GROWTH HORMONE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RADIUS; SEX DIFFERENCE; XRAY SPECTROMETRY;

ACROMEGALY; ADULT; BONE DENSITY; BONE RESORPTION; COLLAGEN TYPE I; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOCALCIN; OSTEOGENESIS; PROSPECTIVE STUDIES;

EID: 33845271474     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02285     Document Type: Article

References (34)

1. Ezzat S, Melmed S, Endres D, Eyre DR & Singer FR. Biochemical assessment of boneformation and resorption in acromegaly. Journal of Clinical Endocrinology and Metabolism 1993 76 1452-1457.
2. Halse J & Gordeladze JO. Urinary hydroxyproline excretion in acromegaly. Acta Endocrinologica 1978 89 483-491.
3. Kotzmann H, Bernecker P, Hubsch P, Pietschmann P, Woloszczuk W, Svoboda T, Geyer G & Luger A. Bone mineral density and parameters of bone metabolism in patients with acromegaly. Journal of Bone and Mineral Research 1993 8 459-465.
4. Kayath MJ & Vieira JG. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine. Osteoporosis International 1997 7 226-230.
5. Halse J, Nielsen F & Mosekilde L. Iliac crest bone mass and remodelling in acromegaly. Acta Endocrinologica 1981 97 18-22.
6. Bolanowski M, Daroszewski J, Medras M & Zadrozna-Sliwka B. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. Journal of Bone and Mineral Metabolism 2006 24 72-78.
7. Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M, Pileri M, Guglielmi G, Di Giorgio A, Modoni S, Fusilli S, Di Cerbo A & Liuzzi A. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients. Journal of Bone and Mineral Research 1997 12 1729-1736.
8. Bijlsma JW, Nortier JW, Duursma SA, Croughs RJ, Bosch R & Thijssen JH. Changes in bone metabolism during treatment of acromegaly, Acta Endocrinologica 1983 104 153-159.
9. Terzolo M, Piovesan A, Osella G, Pia A, Reimondo G, Pozzi C, Raucci C, Torta M, Paccotti P & Angeli A. Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment. Calcified Tissue International 1993 52 188-191.
10. Le Roith D, Bondy C, Yakar S, Liu JL & Butler A. The somatomedin hypothesis. Endocrine Reviews 2001 22 53-74.
11. Yakar S & Rosen CJ. From mouse to man: redefining the role of insulin-like growth factor-I in the acquisition of bone mass. Experimental Biology and Medicine 2003 228 245-252.
12. Aloia JF, Petrak Z, Ellis K & Cohn SH. Body composition and skeletal metabolism following pituitary irradiation in acromegaly. American Journal of Medicine 1976 61 59-63.
13. Diamond T, Nery L & Posen S. Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Annals of Internal Medicine 1989 111 567-573.
14. Seeman E, Wahner HW, Offord KP, Kumar R, Johnson WJ & Riggs BL. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. Journal of Clinical Investigation 1982 69 1302-1309.
15. Lesse GP, Fraser WD, Farquharson R, Hipkin L & Vora JP. Gonadal status is an important determinant of bone density in acromegaly. Clinical Endocrinology 1998 48 59-65.
16. Longobardi S, Di Somma C, Di Rella F, Angelillo N, Ferone D, Colao A, Merola B & Lombardi G. Bone mineral density and circulating cytokines in patients with acromegaly. Journal of Endocrinological Investigation 1998 21 688-693.
17. Scillitani A, Battista C, Chiodini I, Carnevale V, Fusilli S, Ciccarelli E, Terzolo M, Oppizzi G, Arosio M, Gasperi M, Arnaldi G, Colao A, Baldelli R, Ghiggi MR, Gaia D, Di Somma C, Trischitta V & Liuzzi A. Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clinical Endocrinology 2003 58 725-731.
18. Bolanowski M, Wielgus W, Milewicz A & Marciniak R. Axial bone mineral density in patients with acromegaly. Academic Radiology 2000 7 592-594.
19. Ho PJ, Fig LM, Barkan AL & Shapiro B. Bone mineral density of the axial skeleton in acromegaly. Journal of Nuclear Medicine 1992 33 1608-1612.
20. Ueland T, Ebbesen EN, Thomsen JS, Mosekilde L, Brixen K, Flyvbjerg A & Bollerslev J. Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. European Journal of Clinical Investigation 2002 32 122-128.
21. Bonadonna S, Mazziotti G, Nuzzo M, Bianchi A, Fusco A, De Marinis L & Giustina A. Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. Journal of Bone and Mineral Research 2005 20 1837-1844.
22. Morris PD, Malkin CJ, Channer KS & Jones TH. A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men. European Journal of Endocrinology 2004 151 241-249.
23. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 3666-3672.
24. Vermeulen A. Hormonal cut-offs of partial androgen deficiency: a survey of androgen assays. Journal of Endocrinological Investigation 2005 28 28-31.
25. Godang K, Ueland T & Bollerslev J. Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome. European Journal of Endocrinology 1999 141 126-131.
26. de la PC, Larranaga J, Castro N, Horcajada C, Rapado A, Herrera Pombo JL & Carbo E. Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly. Calcified Tissue International 1988 43 44-45.
27. Marazuela M, Astigarraga B, Tabuenca MJ, Estrada J, Marin F & Lucas T. Serum bone Gla protein as a marker of bone turnover in acromegaly. Calcified Tissue International 1993 52 419-421.
28. Guicheux J, Heymann D, Rousselle AV, Gouin F, Pilet P, Yamada S & Daculsi G. Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I: an in vitro study. Bone 1998 22 25-31.
29. Kanatani M, Sugimoto T, Nishiyama K & Chihara K. Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity. Journal of Bone and Mineral Research 2000 15 902-910.
30. Hill PA, Reynolds JJ & Meikle MC. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology 1995 136 124-131.
31. Jonsson KB, Wiberg K, Ljunghall S & Ljunggren O. Insulin-like growth factor I does not stimulate bone resorption in cultured neonatal mouse calvarial bones. Calcified Tissue International 1996 59 366-370.
32. Ernst M & Froesch ER. Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. Biochemical and Biophysical Research Communications 1988 151 142-147.
33. Ueland T, Bollerslev J, Hansen TB, Ebbesen EN, Mosekilde L, Brixen K, Flyvbjerg A & Djoseland O. Increased cortical bone content of insulin-like growth factors in acromegalic patients. Journal of Clinical Endocrinology and Metabolism 1999 84 123-127.
34. Gjesdal CG, Aanderud SJ, Haga HJ, Brun JG & Tell GS. Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: suitability of the reference values. Osteoporosis International 2004 15 525-534.